Sentence: As CDK7 inhibitors are currently under clinical evaluation in patients , our data suggest the addition of the TKI ponatinib or lapatinib in CDK7 inhibitor clinical trials in patients .
Drug combination annotation:
[{'class': 'POS', 'spans': ['lapatinib', 'CDK7 inhibitor'], 'is_context_needed': False}, {'class': 'POS', 'spans': [0, 2], 'is_context_needed': False}]